{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-2.5-pro",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "LY900018",
        "type": {
          "id": "d11fd1bf-ba62-400c-b473-e761afa20674",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "09181534-6063-408f-904b-795dbdbace4c",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Nasal glucagon (LY900018) is a powder formulation of human glucagon for the rescue treatment of hypoglycemia.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "GlucaGen",
        "type": {
          "id": "3ebb21ac-b2ac-4ca7-8f2b-6e13d53b823c",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "40dae42f-e7e9-4b37-9527-706af3c4756d",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Intramuscular glucagon (IMG) used as an active comparator.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Human regular insulin",
        "type": {
          "id": "513c2194-54c8-48af-8e91-068bcd8a9683",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "ae69c83f-95c6-4b84-a8be-345b4a5a7392",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered via IV infusion to induce hypoglycemia as part of the study procedure.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "IV glucose",
        "type": {
          "id": "596c2be7-c515-4fc2-b142-567497f686e4",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "2bea3881-51db-4026-882a-8199da2ce464",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered if a patient has an insufficient response to glucagon administration.",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "LY900018",
        "administrableDoseForm": {
          "id": "dfd89f21-497c-4428-aaec-b341901910b9",
          "code": "C42970",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Powder",
          "standardCode": {
            "id": "5bd0fdcb-770e-44be-a12a-49f70fb62b96",
            "code": "C42970",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Powder",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "fb096192-9dc7-47fa-aa54-c01a9a949f5a",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "3 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Lilly"
      },
      {
        "id": "prod_2",
        "name": "GlucaGen",
        "administrableDoseForm": {
          "id": "c605e16e-4aa3-40ec-902d-c67a492b6f2e",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "81cb9d6b-c85e-443c-a033-7d6410880ee8",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "9aa38952-c5dd-4a73-bb15-4c8144b9eace",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "1 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "id": "prod_3",
        "name": "Human regular insulin",
        "administrableDoseForm": {
          "id": "bd6c2aa2-cc0b-42b5-a630-b7fae19fca01",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "49d8b48e-7519-4fa4-8e12-557a74c2a1ac",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "285584ff-25c5-449d-b2e9-f0779d528d26",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "100 U/mL",
        "substanceIds": [
          "sub_3"
        ]
      },
      {
        "id": "prod_4",
        "name": "IV glucose",
        "administrableDoseForm": {
          "id": "c7e6b3f4-cea8-457a-a01c-faa5e0ac408d",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "a924b5e6-3e5f-43ba-9fb3-5e7b4c274525",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "51e9e82e-7151-45b0-ac48-7aa4ea029dce",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "LY900018",
        "instanceType": "Administration",
        "dose": "3 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intranasal",
          "codeSystem": "USDM",
          "decode": "Intranasal"
        },
        "duration": "Single administration per treatment period"
      },
      {
        "id": "admin_2",
        "name": "GlucaGen",
        "instanceType": "Administration",
        "dose": "1 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Single administration per treatment period"
      },
      {
        "id": "admin_3",
        "name": "Human regular insulin infusion",
        "instanceType": "Administration",
        "dose": "2 mU/kg/min, adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM",
        "doseFrequency": "Continuous infusion",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until bedside plasma glucose level is <60 mg/dL"
      },
      {
        "id": "admin_4",
        "name": "IV glucose rescue",
        "instanceType": "Administration",
        "dose": "As deemed clinically necessary",
        "doseFrequency": "As needed",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until hypoglycemia is resolved"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "glucagon",
        "instanceType": "Substance",
        "description": "Active ingredient in LY900018 and GlucaGen. A synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "id": "sub_2",
        "name": "human regular insulin",
        "instanceType": "Substance",
        "description": "Active ingredient used to induce hypoglycemia."
      },
      {
        "id": "sub_3",
        "name": "glucose",
        "instanceType": "Substance",
        "description": "Active ingredient for rescue treatment of hypoglycemia."
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Nasal delivery device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Lilly"
      }
    ],
    "summary": {
      "interventionCount": 4,
      "productCount": 4,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "LY900018",
        "role": "Investigational Product",
        "description": "Nasal glucagon (LY900018) is a powder formulation of human glucagon for the rescue treatment of hypoglycemia."
      },
      {
        "name": "GlucaGen",
        "role": "Comparator",
        "description": "Intramuscular glucagon (IMG) used as an active comparator."
      },
      {
        "name": "Human regular insulin",
        "role": "Concomitant Medication",
        "description": "Administered via IV infusion to induce hypoglycemia as part of the study procedure."
      },
      {
        "name": "IV glucose",
        "role": "Rescue Medication",
        "description": "Administered if a patient has an insufficient response to glucagon administration."
      }
    ],
    "products": [
      {
        "name": "LY900018",
        "doseForm": "Nasal powder",
        "strength": "3 mg",
        "manufacturer": "Lilly"
      },
      {
        "name": "GlucaGen",
        "doseForm": "Powder for injection",
        "strength": "1 mg",
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "name": "Human regular insulin",
        "doseForm": "Solution for infusion",
        "strength": "100 U/mL",
        "manufacturer": null
      },
      {
        "name": "IV glucose",
        "doseForm": "Solution for infusion",
        "strength": null,
        "manufacturer": null
      }
    ],
    "substances": [
      {
        "name": "glucagon",
        "description": "Active ingredient in LY900018 and GlucaGen. A synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "name": "human regular insulin",
        "description": "Active ingredient used to induce hypoglycemia."
      },
      {
        "name": "glucose",
        "description": "Active ingredient for rescue treatment of hypoglycemia."
      }
    ],
    "administrations": [
      {
        "name": "LY900018",
        "dose": "3 mg",
        "frequency": "Single dose",
        "route": "Intranasal",
        "duration": "Single administration per treatment period"
      },
      {
        "name": "GlucaGen",
        "dose": "1 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Single administration per treatment period"
      },
      {
        "name": "Human regular insulin infusion",
        "dose": "2 mU/kg/min, adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM",
        "frequency": "Continuous infusion",
        "route": "Intravenous",
        "duration": "Until bedside plasma glucose level is <60 mg/dL"
      },
      {
        "name": "IV glucose rescue",
        "dose": "As deemed clinically necessary",
        "frequency": "As needed",
        "route": "Intravenous",
        "duration": "Until hypoglycemia is resolved"
      }
    ],
    "devices": [
      {
        "name": "Nasal delivery device",
        "manufacturer": "Lilly",
        "purpose": "Included as part of the investigational drug product (LY900018) to deliver the contained drug constituent into the nasal cavity."
      }
    ]
  }
}